{
    "Relevant Biomarkers": [
        {
            "BioMarker": "ERCC2",
            "Method": "Seq",
            "Analyte": "DNA-Tumor",
            "Result": "Stable"
        },
        {
            "BioMarker": "IDH1",
            "Method": "Seq",
            "Analyte": "DNA-Tumor",
            "Result": "Fusion not detected"
        },
        {
            "BioMarker": "MUTYH",
            "Method": "Seq",
            "Analyte": "DNA-Tumor",
            "Result": "Stable"
        },
        {
            "BioMarker": "MYOD1",
            "Method": "Seq",
            "Analyte": "DNA-Tumor",
            "Result": "Stable"
        },
        {
            "BioMarker": "PD-L1(SP142)",
            "Method": "IHC",
            "Analyte": "Protien",
            "Result": "Positive| 1+, 37%"
        },
        {
            "BioMarker": "HDAC2",
            "Method": "Seq",
            "Analyte": "RNA-Tumor",
            "Result": "Mutation not detected"
        },
        {
            "BioMarker": "ER",
            "Method": "IHC",
            "Analyte": "Protien",
            "Result": "Negative| 3+, 31%"
        },
        {
            "BioMarker": "JAK2",
            "Method": "Seq",
            "Analyte": "RNA-Tumor",
            "Result": "Mutation not detected"
        }
    ],
    "Genomic Signatures": [
        {
            "BioMarker": "Microsatellite instability",
            "Method": "Seq",
            "Analyte": "DNA tumor",
            "Result": "Low"
        },
        {
            "BioMarker": "Tumor mutational burden",
            "Method": "Seq",
            "Analyte": "DNA tumor",
            "Result": "9 mutations/Mb Low"
        },
        {
            "BioMarker": "Genomic loss of heterozygosity (LOH)",
            "Method": "Seq",
            "Analyte": "DNA tumor",
            "Result": "Low - 5% of tested genmoic segments exhibit LOH"
        }
    ],
    "Genes Tested with Pathogenic Alterations": [
        {
            "Gene": "SF3B1",
            "Method": "Seq",
            "Analyte": "DNA tumor",
            "Variant Interpretation": "Pathogenic",
            "Protien Alteration": "p.P128L",
            "Exon": 12,
            "DNA Alteration": "c.383C>T",
            "Allele Frequency %": "39.19"
        },
        {
            "Gene": "HDAC1",
            "Method": "Seq",
            "Analyte": "DNA tumor",
            "Variant Interpretation": "Likely Pathogenic",
            "Protien Alteration": " p.W266*",
            "Exon": 16,
            "DNA Alteration": " c.798G>A",
            "Allele Frequency %": "7.58"
        },
        {
            "Gene": "MAP2K2",
            "Method": "Seq",
            "Analyte": "DNA tumor",
            "Variant Interpretation": "Benign",
            "Protien Alteration": "p.I157T",
            "Exon": 5,
            "DNA Alteration": "c.470T>C",
            "Allele Frequency %": "19.98"
        },
        {
            "Gene": "NRAS",
            "Method": "Seq",
            "Analyte": "DNA tumor",
            "Variant Interpretation": "Likely Benign",
            "Protien Alteration": "p.N159Y",
            "Exon": 8,
            "DNA Alteration": ">",
            "Allele Frequency %": "8.18"
        },
        {
            "Gene": "EGFR",
            "Method": "Seq",
            "Analyte": "DNA tumor",
            "Variant Interpretation": "Pathogenic",
            "Protien Alteration": "p.Y736fs*4",
            "Exon": 3,
            "DNA Alteration": "c.2207_2212delinsTAGATTC",
            "Allele Frequency %": "16.21"
        }
    ]
}